Home
/
IMMUCELL CORP /DE/
/
Financials
/
Quarterly
IMMUCELL CORP /DE/ — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that IMMUCELL CORP /DE/ filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q2
2025
Jun 30, 2025
$6.44M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$8.07M
May 14, 2025
Q3
2024
Sep 30, 2024
$6.01M
Nov 13, 2024
Q2
2025
Jun 30, 2024
$5.47M
Aug 14, 2025
Q1
2025
Mar 31, 2024
$7.26M
May 14, 2025
Q3
2024
Sep 30, 2023
$5.40M
Nov 13, 2024
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$5.51M
Nov 13, 2025
Q3
2025
Dec 31, 2024
$26.49M
Nov 13, 2025
Q3
2025
Sep 30, 2024
$6.01M
Nov 13, 2025
Q3
2023
Sep 30, 2023
$5.40M
Nov 13, 2023
Q3
2023
Dec 31, 2022
$18.57M
Nov 13, 2023
Q3
2023
Sep 30, 2022
$4.80M
Nov 13, 2023
Q3
2023
Dec 31, 2021
$19.24M
Nov 13, 2023
Q3
2022
Sep 30, 2021
$5.15M
Nov 21, 2022
Q3
2022
Dec 31, 2020
$15.34M
Nov 21, 2022
Q2
2018
Jun 30, 2018
$3.01M
Aug 13, 2018
Q1
2018
Mar 31, 2018
$2.88M
May 14, 2018
Q2
2018
Jun 30, 2017
$1.75M
Aug 13, 2018
Q1
2018
Mar 31, 2017
$3.54M
May 14, 2018
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($139.7K)
Nov 13, 2025
Q2
2025
Jun 30, 2025
$501.9K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$1.45M
May 14, 2025
Q3
2025
Sep 30, 2024
($701.7K)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.53M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($437.9K)
May 14, 2025
Q3
2024
Sep 30, 2023
($940.0K)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($1.38M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($2.32M)
May 14, 2024
Q3
2023
Sep 30, 2022
($655.1K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($684.1K)
Aug 10, 2023
Q1
2023
Mar 31, 2022
$513.3K
May 11, 2023
Q3
2022
Sep 30, 2021
$147.8K
Nov 21, 2022
Q2
2022
Jun 30, 2021
$141.1K
Nov 21, 2022
Q1
2022
Mar 31, 2021
($441.3K)
Nov 21, 2022
Q3
2021
Sep 30, 2020
($322.9K)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($765.8K)
Aug 12, 2021
Q1
2021
Mar 31, 2020
($122.3K)
May 13, 2021
Q3
2020
Sep 30, 2019
($502.5K)
Nov 12, 2020
Q2
2020
Jun 30, 2019
($627.2K)
Aug 12, 2020
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$20.1K
Nov 13, 2025
Q2
2025
Jun 30, 2025
$569.6K
Aug 14, 2025
Q1
2025
Mar 31, 2025
$1.12M
May 14, 2025
Q3
2025
Dec 31, 2024
($1.64M)
Nov 13, 2025
Q3
2025
Sep 30, 2024
($574.9K)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($1.39M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($300.1K)
May 14, 2025
Q3
2024
Dec 31, 2023
($5.75M)
Nov 13, 2024
Q2
2024
Dec 31, 2023
($5.75M)
Aug 13, 2024
Q1
2024
Dec 31, 2023
($5.75M)
May 14, 2024
Q3
2024
Sep 30, 2023
($1.18M)
Nov 13, 2024
Q2
2024
Jun 30, 2023
($1.30M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($2.26M)
May 14, 2024
Q2
2024
Dec 31, 2022
($2.30M)
Aug 13, 2024
Q1
2024
Dec 31, 2022
($2.30M)
May 14, 2024
Q3
2024
Dec 31, 2022
($2.30M)
Nov 13, 2024
Q3
2023
Sep 30, 2022
($616.8K)
Nov 13, 2023
Q2
2023
Jun 30, 2022
($619.0K)
Aug 10, 2023
Q1
2023
Mar 31, 2022
$570.6K
May 11, 2023
Q2
2023
Dec 31, 2021
$257.4K
Aug 10, 2023